NUS Total Assets from 2010 to 2024

NUS Stock

USD 6.45 0.03 0.46%

Nu Skin Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 1.2 B in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1995-12-31

Previous Quarter

1.7 B

Current Value

1.6 B

Quarterly Volatility

551.4 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0844 or PTB Ratio of 1.12. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.

Check out the analysis of Nu Skin Correlation against competitors.

Latest Nu Skin's Total Assets Growth Pattern

Below is the plot of the Total Assets of Nu Skin Enterprises over the last few years. Total assets refers to the total amount of Nu Skin assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nu Skin Enterprises books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Nu Skin's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.81 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

NUS Total Assets Regression Statistics

	Arithmetic Mean	1,492,040,262
	Geometric Mean	1,313,452,898
	Coefficient Of Variation	32.10
	Mean Deviation	342,033,251
	Median	1,614,434,000
	Standard Deviation	478,884,691
	Sample Variance	229330.5T
	Range	1.8B
	R-Value	0.59
	Mean Square Error	161541.5T
	R-Squared	0.35
	Significance	0.02
	Slope	62,979,248
	Total Sum of Squares	3210627.7T

NUS Total Assets History

	2024	1.2 B
	2023	1.8 B
	2022	1.8 B
	2021	1.9 B
	2020	2 B
	2019	1.8 B
	2018	1.7 B

Other Fundumenentals of Nu Skin Enterprises

Intangibles To Total Assets

Nu Skin Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Good Will	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.96	0.22	0.96	0.76	0.62	0.97	0.91	0.05	0.56	-0.19	-0.36	0.44	0.91	-0.54	0.26	-0.8	0.89	0.57	0.76	-0.26	-0.07	0.37	0.29	0.09	0.26
Total Stockholder Equity	0.96		0.15	0.91	0.66	0.54	0.87	0.89	-0.01	0.46	-0.25	-0.44	0.31	0.87	-0.62	0.26	-0.68	0.91	0.41	0.66	-0.21	-0.09	0.3	0.24	0.13	0.21
Net Debt	0.22	0.15		0.38	-0.18	0.43	0.26	-0.14	-0.16	0.71	0.14	0.51	0.89	0.31	0.08	-0.38	-0.67	0.44	0.78	0.74	-0.7	-0.64	0.87	0.8	-0.66	0.73
Retained Earnings	0.96	0.91	0.38		0.61	0.5	0.94	0.77	0.03	0.64	-0.25	-0.3	0.55	0.93	-0.47	0.08	-0.88	0.85	0.69	0.84	-0.31	-0.14	0.44	0.35	0.1	0.35
Accounts Payable	0.76	0.66	-0.18	0.61		0.62	0.79	0.88	0.0	0.27	-0.02	-0.4	0.14	0.53	-0.41	0.64	-0.47	0.55	0.28	0.4	-0.09	0.11	0.14	0.1	0.14	0.08
Net Receivables	0.62	0.54	0.43	0.5	0.62		0.64	0.56	-0.24	0.54	0.34	0.21	0.63	0.47	-0.37	0.37	-0.57	0.74	0.56	0.65	-0.63	-0.41	0.67	0.62	-0.59	0.43
Total Liab	0.97	0.87	0.26	0.94	0.79	0.64		0.87	0.09	0.61	-0.12	-0.28	0.52	0.9	-0.44	0.25	-0.84	0.82	0.66	0.81	-0.29	-0.05	0.42	0.32	0.06	0.28
Total Current Assets	0.91	0.89	-0.14	0.77	0.88	0.56	0.87		0.16	0.25	-0.23	-0.52	0.15	0.78	-0.59	0.48	-0.56	0.76	0.26	0.48	0.0	0.14	0.1	0.03	0.2	0.03
Short Term Debt	0.05	-0.01	-0.16	0.03	0.0	-0.24	0.09	0.16		-0.14	-0.18	-0.06	-0.16	0.2	0.21	0.06	-0.06	-0.03	-0.21	-0.02	0.58	0.45	-0.2	-0.5	0.18	-0.13
Good Will	0.56	0.46	0.71	0.64	0.27	0.54	0.61	0.25	-0.14		0.34	0.24	0.68	0.5	0.16	-0.06	-0.74	0.6	0.78	0.9	-0.59	-0.46	0.85	0.72	-0.2	0.62
Intangible Assets	-0.19	-0.25	0.14	-0.25	-0.02	0.34	-0.12	-0.23	-0.18	0.34		0.62	0.07	-0.28	0.29	0.09	0.21	-0.04	0.07	0.09	-0.24	-0.24	0.28	0.14	-0.32	0.09
Common Stock	-0.36	-0.44	0.51	-0.3	-0.4	0.21	-0.28	-0.52	-0.06	0.24	0.62		0.36	-0.23	0.41	-0.27	0.1	-0.05	0.25	0.18	-0.39	-0.6	0.41	0.3	-0.67	0.44
Long Term Debt	0.44	0.31	0.89	0.55	0.14	0.63	0.52	0.15	-0.16	0.68	0.07	0.36		0.51	-0.17	-0.29	-0.81	0.54	0.92	0.81	-0.71	-0.49	0.82	0.79	-0.64	0.62
Property Plant Equipment	0.91	0.87	0.31	0.93	0.53	0.47	0.9	0.78	0.2	0.5	-0.28	-0.23	0.51		-0.5	-0.02	-0.8	0.84	0.62	0.77	-0.25	-0.05	0.3	0.23	0.08	0.2
Current Deferred Revenue	-0.54	-0.62	0.08	-0.47	-0.41	-0.37	-0.44	-0.59	0.21	0.16	0.29	0.41	-0.17	-0.5		-0.07	0.27	-0.51	-0.13	-0.12	0.01	-0.02	0.11	0.05	0.07	0.09
Short Term Investments	0.26	0.26	-0.38	0.08	0.64	0.37	0.25	0.48	0.06	-0.06	0.09	-0.27	-0.29	-0.02	-0.07		0.04	0.18	-0.25	-0.06	0.08	0.18	-0.06	-0.16	0.08	-0.04
Treasury Stock	-0.8	-0.68	-0.67	-0.88	-0.47	-0.57	-0.84	-0.56	-0.06	-0.74	0.21	0.1	-0.81	-0.8	0.27	0.04		-0.74	-0.84	-0.91	0.48	0.23	-0.7	-0.61	0.22	-0.53
Net Tangible Assets	0.89	0.91	0.44	0.85	0.55	0.74	0.82	0.76	-0.03	0.6	-0.04	-0.05	0.54	0.84	-0.51	0.18	-0.74		0.56	0.81	-0.44	-0.38	0.57	0.47	-0.24	0.47
Long Term Debt Total	0.57	0.41	0.78	0.69	0.28	0.56	0.66	0.26	-0.21	0.78	0.07	0.25	0.92	0.62	-0.13	-0.25	-0.84	0.56		0.88	-0.65	-0.44	0.73	0.71	-0.36	0.56
Capital Surpluse	0.76	0.66	0.74	0.84	0.4	0.65	0.81	0.48	-0.02	0.9	0.09	0.18	0.81	0.77	-0.12	-0.06	-0.91	0.81	0.88		-0.59	-0.45	0.81	0.68	-0.28	0.64
Short Long Term Debt	-0.26	-0.21	-0.7	-0.31	-0.09	-0.63	-0.29	0.0	0.58	-0.59	-0.24	-0.39	-0.71	-0.25	0.01	0.08	0.48	-0.44	-0.65	-0.59		0.55	-0.69	-0.87	0.54	-0.41
Cash And Equivalents	-0.07	-0.09	-0.64	-0.14	0.11	-0.41	-0.05	0.14	0.45	-0.46	-0.24	-0.6	-0.49	-0.05	-0.02	0.18	0.23	-0.38	-0.44	-0.45	0.55		-0.66	-0.65	0.58	-0.81
Net Invested Capital	0.37	0.3	0.87	0.44	0.14	0.67	0.42	0.1	-0.2	0.85	0.28	0.41	0.82	0.3	0.11	-0.06	-0.7	0.57	0.73	0.81	-0.69	-0.66		0.89	-0.64	0.83
Net Working Capital	0.29	0.24	0.8	0.35	0.1	0.62	0.32	0.03	-0.5	0.72	0.14	0.3	0.79	0.23	0.05	-0.16	-0.61	0.47	0.71	0.68	-0.87	-0.65	0.89		-0.58	0.67
Capital Stock	0.09	0.13	-0.66	0.1	0.14	-0.59	0.06	0.2	0.18	-0.2	-0.32	-0.67	-0.64	0.08	0.07	0.08	0.22	-0.24	-0.36	-0.28	0.54	0.58	-0.64	-0.58		-0.55
Long Term Investments	0.26	0.21	0.73	0.35	0.08	0.43	0.28	0.03	-0.13	0.62	0.09	0.44	0.62	0.2	0.09	-0.04	-0.53	0.47	0.56	0.64	-0.41	-0.81	0.83	0.67	-0.55

Click cells to compare fundamentals

About Nu Skin Financial Statements

Nu Skin shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	1.8 B	1.2 B
Intangibles To Total Assets	0.19	0.22

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC